1426099-71-9

Upstream product

• 1138124-35-2 C₄₄H₄₈Cl₃NO₁₉ 
• 1138125-17-3 C₄₂H₄₆Cl₃NO₁₈ 
• 1138123-83-7 C₄₂H₄₄Cl₃NO₁₈ 
• 3150-20-7 4-methoxyphenyl β-D-galactopyranoside 
• 150-76-5 4-methoxy-phenol 
• 2872-65-3 4-methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 25878-60-8 D-galactose pentaacetate 
• 187022-49-7 (2R,3S,4R,5R,6S)-2-(acetoxymethyl)-6-(phenylthio)-5-(((2,2,2-trichloroethoxy)carbonyl)amino)tetrahydro-2H-pyran-3,4-diyl diacetate 
• 1138123-66-6 phenyl 3,4,6-tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranoside S-oxide 
• 1885-14-9 phenyl chloroformate 
• 1426099-68-4 C₂₇H₂₆O₉ 
• 176299-96-0 4-methoxyphenyl 4,6-O-benzylidene-β-D-galactopyranoside 

Downstream Products

• 1426099-72-0 C₃₇H₄₀Cl₃NO₂₀ 
• 1426099-74-2 C₃₇H₄₁Cl₃N₂O₁₉ 

Relevant academic research and scientific papers

Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors

New antibiotic drugs need to be identified to address rapidly developing resistance of bacterial pathogens to common antibiotics. The natural antibiotic moenomycin A is the prototype for compounds that bind to bacterial peptidoglycan glycosyltransferases

CHEMOENZYMATIC METHODS FOR SYNTHESIZING MOENOMYCIN ANALOGS

The present invention provides methods of synthesizing moenomycin analogs of Formula (I). The present invention also provides compositions comprising a compound of Formula (I) and kits for synthesizing compounds of Formula (I).